Research Handbook on the Protection of Intellectual Property under WTO Rules

Edited by Carlos M. Correa, Executive Director, South Centre, Geneva, Switzerland

Contents:

Preface
Carlos M. Correa

HISTORY, INTERPRETATION AND PRINCIPLES
1. Why IPR Issues Were Brought to GATT: A Historical Perspective on the Origins of TRIPS
Charles Clift

2. Developing Countries in the Global IP System Before TRIPS: The Political Context for the TRIPS Negotiations
Carolyn Deere-Birkbeck

3. Minimum Standards vs. Harmonization in the TRIPS Context: The Nature of Obligations under TRIPS and Modes of Implementation at the National Level in Monist and Dualist Systems
Denis Borges Barbosa

4. Enhancing Global Innovation Policy: The Role of WIPO and its Conventions in Interpreting the TRIPS Agreement
Graeme B. Dinwoodie and Rochelle C. Dreyfuss

5. The Objectives and Principles of the TRIPS Agreement
Peter K. Yu

6. Mainstreaming the TRIPS and Human Rights Interactions
Xavier Seuba

7. The TRIPS Agreement and Intellectual Property Rights Exhaustion
Luis Mariano Genovesi

8. Intellectual Property Rights and Competition Policy
Beatriz Conde Gallego

9. Intellectual Property Rights in Free Trade Agreements: Moving Beyond TRIPS Minimum Standards
Pedro Roffe, Christoph Spennemann and Johanna von Braun

SUBSTANTIVE RIGHTS
10. Limits, Limitations and Exceptions to Copyright under the TRIPS Agreement
P. Bernt Hugenholtz

11. Copyright in TRIPS and Beyond: The WIPO Internet Treaties
Ruth L. Okediji

12. The Protection of ‘Related Rights’ in TRIPS and the WIPO Performances and Phonograms Treaty
Owen Morgan

13. Marks for Goods or Services (Trademarks)
Annette Kur

14. Unresolved Issues on Geographical Indications in the WTO
Kasturi Das

15. No ‘Lemons’ No More: A Sketch on the ‘Economics’ of Geographical Indications
Dwijen Rangnekar

16. Exploring the Flexibilities of TRIPS to Promote Biotechnology in Developing Countries
Graham Dutfield, Lois Muraguri and Florian Leverve

17. Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options
Jerome H. Reichman

18. The Doha Declaration and Access to Medicines by Countries Without Manufacturing Capacity
S.K. Verma

19. Disease-based Limitations on Compulsory Licenses Under Articles 31 and 31bis
Kevin Outterson

20. The Protection of Semiconductor Chip Products in TRIPS
Thomas Hoeren

21. Data Exclusivity for Pharmaceuticals: TRIPS Standards and Industry’s Demands in Free Trade Agreements
Carlos M. Correa

Index